Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Shoulder Arthroplasty

In brief

The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic acid

Key facts

Study ID

NCT06902714

Run by

University of Alabama at Birmingham

People needed

60

Starts

2026-04-20

Expected to finish

2030-12-01

Last updated by the study team

2026-04-28

Who can join

Age: 18 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Skeletally mature patients (ages 18-79) undergoing primary total shoulder arthroplasty

You may not qualify if…

• Patients with Cancer, venous thromboembolism, stroke, heart disease, pregnant or nursing, allergic to TXA, current tobacco use, anticoagulants other than aspirin.

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.